Stockscreener 앱 받기
153.10
2.03%
3.04
시간 외 거래:
153.70
0.60
+0.39%
전일 마감가:
$150.06
열려 있는:
$149.23
하루 거래량:
1.25M
Relative Volume:
0.70
시가총액:
$9.60B
수익:
$409.48M
순이익/손실:
$-81.28M
주가수익비율:
-115.23
EPS:
-1.3286
순현금흐름:
$-95.14M
1주 성능:
+12.30%
1개월 성능:
+76.91%
6개월 성능:
+226.30%
1년 성능:
+463.07%
1일 변동 폭
$148.44
$155.44
1주일 범위
$135.05
$155.44
52주 변동 폭
$23.30
$155.44
트위스트 바이오사이언스 Stock (TWST) Company Profile
명칭
Twist Bioscience Corp
전화
800-719-0671
주소
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, NTRA, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
153.10 | 8.55B | 409.48M | -81.28M | -95.14M | -1.3286 |
TMO
Thermo Fisher Scientific Inc
|
630.70 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.68 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.70 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
157.69 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.38 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
트위스트 바이오사이언스 Stock (TWST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 개시 | Stephens | Overweight |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-06-04 | 개시 | Guggenheim | Buy |
| 2024-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-09-27 | 개시 | Berenberg | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2023-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2022-03-02 | 재개 | Cowen | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-29 | 개시 | William Blair | Outperform |
| 2021-06-04 | 개시 | Goldman | Neutral |
| 2021-04-12 | 개시 | Piper Sandler | Overweight |
| 2021-02-05 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-10-20 | 개시 | SVB Leerink | Mkt Perform |
| 2019-05-31 | 개시 | Evercore ISI | Outperform |
| 2018-11-26 | 개시 | JP Morgan | Neutral |
모두보기
트위스트 바이오사이언스 주식(TWST)의 최신 뉴스
Twist Bioscience Executive Dennis Cho Sells 14,205 Shares Under 10b5-1 Plan in August 2026 - Kalkine Media
Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook - StocksToTrade
Twist Bioscience (NASDAQ: TWST) seller plans more after $14.2M August stock trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer adds $189K sale after $2.1M June trade - Stock Titan
Twist Bioscience (NASDAQ: TWST) holder to sell 1,965 shares for taxes, compensation - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer booked $1.84M in one sale, now plans more stock trades - Stock Titan
Twist Bioscience (NASDAQ: TWST) insider to sell 669 shares - Stock Titan
Twist Bioscience (NASDAQ: TWST) officer to sell 4,046 shares after $9.2M August sale - Stock Titan
Twist Bioscience Corp (TWST) Stock Down 4.3% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience (TWST) COO sells 78K shares under 10b5-1 plan - Stock Titan
Twist Bioscience stock hits 52-week high at 143.1 USD - Investing.com
Twist Bioscience (NASDAQ:TWST) Shares Gap DownHere's What Happened - MarketBeat
Twist Bioscience stock hits 52-week high at 143.1 USD By Investing.com - Investing.com Canada
Twist Bioscience benefits from Claude's advances in protein design - marketscreener.com
Twist Bioscience Registers 35,114 Shares for Resale by Invenra - Minichart
Twist Bioscience files prospectus supplement for Invenra share resale - Investing.com
Twist Bioscience (NASDAQ: TWST) clears path for 35K-share resale - Stock Titan
Twist Bioscience Stock Rallies As Guidance And Targets Jump - StocksToTrade
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report - Benzinga
Short seller Scorpion Capital bets against Twist Biosciences questioning AI partnership claims - Investing.com
Twist Bioscience Shares Rise After Selection by Anthropic to Evaluate Protein Design Project - marketscreener.com
Twist Bioscience (NASDAQ: TWST) officer may sell $1.84M in shares - Stock Titan
Twist Bioscience jumps as investors build on strong guidance and AI-drug-discovery enthusiasm - Quiver Quantitative
TWST Looks 163.5% Overvalued on GF Value™ - GuruFocus
Twist Bioscience Up Over 17%, on Track for Highest Close Since April 2021 -- Data Talk - Bitget
Twist Bioscience (NASDAQ:TWST) Hits New 52-Week HighShould You Buy? - MarketBeat
Why is Twist Bioscience stock surging today? - Investing.com
Why is Twist Bioscience stock surging today? By Investing.com - Investing.com Canada
Twist Bioscience Selected as Independent Evaluator in Anthropic's AI-Driven Protein Design Initiative - Kalkine Media
Form 8K Twist Bioscience Corp For: 19 August By Investing.com - Investing.com Nigeria
Twist Bioscience selected as evaluator for Anthropic AI protein design project - Investing.com
Anthropic selects Twist Bioscience as independent evaluator for AI-designed protein testing - TradingView
Twist Bioscience (NASDAQ: TWST) insider plans multimillion-dollar stock sale - Stock Titan
A Look at Twist Bioscience Corp (TWST) After 5.0% Gain -- GF Val - GuruFocus
Twist Bioscience (TWST) Is Down 5.1% After Upsized Equity Raise And Guidance Hike Has The Bull Case Changed? - simplywall.st
Bank of America Corp DE Grows Stake in Twist Bioscience Corporation $TWST - MarketBeat
Twist Bioscience CEO Emily Leproust Executes Sale of 19,952 Shares via 10b5-1 Plan - Kalkine Media
Twist Bioscience Corp (TWST) Stock Down 5.4% but Still Overvalued -- GF Score: 69/100 - GuruFocus
Twist Bioscience Director Katryn Blake Executes Sell-to-Cover of 2,240 Shares for RSU Tax Obligations - Kalkine Media
Twist Bioscience (TWST) director sells 2,240 shares to cover RSU tax - Stock Titan
Twist Bioscience (TWST): ARK Investment Management reports 4.55M-share, 7.31% stake - Stock Titan
Twist Bioscience (NASDAQ:TWST) Trading Down 4.3%Here's What Happened - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
T. Rowe Price Associates (TWST) discloses 3.63M-share Twist Bioscience position - Stock Titan
Twist Bioscience (TWST): EdgePoint discloses 4.21% beneficial stake in amended 13G - Stock Titan
Artisan Partners group (TWST) discloses 4.8M-share position in Twist Bioscience - Stock Titan
Twist Bioscience stock hits 52-week high at 126.22 USD By Investing.com - Investing.com Australia
Twist Bioscience stock hits 52-week high at 126.22 USD - Investing.com
Twist Bioscience CEO Emily Leproust Executes Stock Option Exercise and Sells 113,318 Shares Under 10b5-1 Plan - Kalkine Media
Insider Selling: Twist Bioscience (NASDAQ:TWST) CEO Sells $14,182,880.88 in Stock - MarketBeat
Twist Bioscience (TWST) insider Leproust plans resale after option exercise - Stock Titan
트위스트 바이오사이언스 (TWST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
1.51%
자본화:
|
볼륨(24시간):